MEET US
The ECRF is governed by a Council, Executive Board, and Finance Committee. Members ensure the proper use and distribution of the funds to research and follow-up projects.
In addition, three elected members from the ECRF sit on the EORTC General Assembly to ensure communication between members.
Since 2014, ECRF has been privileged to count Prince Albert II of Monaco as its Honorary President and Count Diego du Monceau de Bergendal as the Chairman of the Fund.
WHY WE ARE UNIQUE
WHAT WE FOCUS ON
ECRF’s mission is to promote, encourage and
support clinical research on the treatment of cancer
under the auspices of the EORTC.

ECRF KEY DATES
-
EORTC Fellowship Program is launched. Fellows from around the world spend 1 to 3 years at EORTC headquarters, engaged in work related to EORTC research projects or programs and becoming familiar with practical aspects of clinical research including clinical trial methodology, regulatory affairs, data management, statistics, medical monitoring and the reporting of results.
-
- ECRF receives annual core support of €1.3 million from various European national cancer charities and the Hong Kong Cancer Fund.
- Launch of Sallie Snowman Survivorship Initiative, studying key clinical questions concerning long-term cognitive effects in patients after a cancer treatment. This initiative also addresses cancer socio-economical and psychological issues.
-
- EORTC Survivorship Gala
- Princess Astrid of Belgium passes ECRF Honorary Presidency
to H.S.H Prince Albert II of Monaco - Sir Ronald Grierson, EORTC Foundation founding Chairman, retires
- Sir Christopher Mallaby retires to become Honorary Vice President
- Count Diego du Monceau de Bergendal becomes Chairman
- Professor John Smyth becomes ECRF Vice Chairman
- Transatlantic Rare Cancers Initiative begins.
- 1976
- 1991
- 1992
- 1997
- 2003
- 2011
- 2012
- 2013
- 2014
- 2015
- 2016
- 2018
- 2019